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In the last decade it has become clear that, similarly to nucleated cells, enucleated red
blood cells (RBCs) are susceptible to programmed apoptotic cell death. Erythrocytic
apoptosis seems to play a role in physiological clearance of aged RBCs, but it may
also be implicated in anemia of different etiological sources including drug therapy and
infectious diseases. In malaria, severe anemia is a common complication leading to
death of children and pregnant women living in malaria-endemic regions of Africa. The
pathogenesis of malarial anemia is multifactorial and involves both ineffective production
of RBCs by the bone marrow and premature elimination of non-parasitized RBCs,
phenomena potentially associated with apoptosis. In the present overview, we discuss
evidences associating erythrocytic apoptosis with the pathogenesis of severe malarial
anemia, as well as with regulation of parasite clearance in malaria. Efforts to understand
the role of erythrocytic apoptosis in malarial anemia can help to identify potential targets
for therapeutic intervention based on apoptotic pathways and consequently, mitigate the
harmful impact of malaria in global public health.
Keywords: malaria, anemia, apoptosis, red blood cells, phagocytosis
INTRODUCTION
Kerr and colleagues introduced the term apoptosis in 1972 to designate a physiologic process of
programmed cell death implicated in normal maintenance of tissue cell population as well as in
development of pathologies such as cancer. Since then, an enormous number of studies focusing
on apoptosis have been published. These studies have focused on apoptosis of nucleated cells, whose
dramatic changes occurring in the nucleus, i.e., chromatin condensation and DNA fragmentation
(Kerr et al., 1972; Wyllie, 1980; Totino et al., 2006), labeled apoptosis as a nucleus-dependent
stereotyped process. However, pioneer studies with experimentally enucleated cells demonstrated
that typical cytoplasmic and cell membrane features of apoptosis, such as membrane blebbing, cell
shrinkage, loss of mitochondrial transmembrane potential, and exposure of phosphatidylserine
can be induced in the absence of a nucleus (Jacobson et al., 1994; Schulze-Osthoff et al., 1994;
Castedo et al., 1996), raising the possibility that apoptosis could also determine the life span of
physiologically enucleated cells, i.e., the red blood cells (RBC).
Indeed, even the lack of organelles in RBCs, including those directly implicated in apoptosis
induction (i.e., mitochondria and endoplasmic reticulum), does not impair activation of the
cytoplasmic machinery present in the cell that coordinates the apoptotic process (Bratosin et al.,
2001; Lang et al., 2012). Although the pathways leading to apoptosis in RBC are not well known,
they have been shown to be initiated by an increase in cytosolic Ca2+ due to activation of Ca2+
permeable non-selective cation channels in the cell membrane, which can be triggered by a variety
of xenobiotics and endogenous substances (Lang et al., 2012). In turn, influx of Ca2+ leads to (1)
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activation of caspases and calpains, which participate in cell
disassembly and formation of cell membrane blebbing; (2) cell
shrinkage through exit of K+ via Ca2+-sensitive K+ channel;
and (3) stimulation of cell membrane scrambling, resulting in
phosphatidylserine (PS) exposure at the cell surface (Gao et al.,
2012; Lang et al., 2012). This last event is critical for elimination
of apoptotic cells, before cell disintegration, and subsequent
release of cytoplasmic proinflammatory mediators, because PS
works as an “eat me” signal for phagocytic cells that operate in
an anti-inflammatory manner (Wu et al., 2006).
Similarly to apoptosis of nucleated cells, apoptosis of
erythrocytes participates in the body homeostasis through
physiological clearance of aged cells. It is estimated that 360
billion of senescent erythrocytes undergo apoptotic processes
and are removed every day by the spleen, avoiding systemic
complications related to intravascular hemolysis (Bratosin et al.,
1998, 2009). On the other hand, apoptosis is also believed to
contribute to anemia and vascular disorders associated with
clinical conditions in which excessive rates of apoptotic RBCs are
documented, including diabetes, renal insufficiency, sickle-cell
anemia, chronic lead exposure (Lang et al., 2002; Myssina et al.,
2003; Calderón-Salinas et al., 2011; Aguilar-Dorado et al., 2014)
as well as infectious diseases such as sepsis and mycoplasmosis
(Kempe et al., 2007; Felder et al., 2011).
In view of the pathophysiological significance of erythrocytic
apoptosis, our group has attempted to study this erythrocytic
process in malaria, a vector-borne infection caused by protozoa
of the genus Plasmodium that infect RBCs and induce strong
hematologic and vascular disturbances (Anstey et al., 2009; Grau
and Craig, 2012; Carvalho et al., 2014). Our studies have shown
that induction of apoptosis is not limited to parasitized RBCs
(pRBCs) but also occurs in non-parasitized RBCs (nRBCs),
pointing to an involvement of both pRBC and nRBC in the
pathogenesis of malaria through deflagration of suicide processes
(Totino et al., 2009, 2011, 2013, 2014). Thus, the present
review covers evidence implicating erythrocytic apoptosis in
the pathogenesis of severe anemia, a common complication
of malaria that represents an important public health concern
strongly related to mortality in children and pregnant women
living in malaria-hyperendemic regions of sub-Saharan Africa
(Schantz-Dunn and Nour, 2009; Muoneke et al., 2012).
MALARIAL ANEMIA AND RBC REMOVAL
It should not be a surprise that anemia is one of themost common
disorders associated with malaria, because Plasmodium parasites
develop an intraerythrocytic schizogony process culminating in
lysis of RBCs. In non-immune children and adults infected
with P. falciparum, the degree of anemia may correlate with
parasitemia (Phillips and Pasvol, 1992; Biemba et al., 2000;
Menendez et al., 2000) and in most experimental rodent malaria,
acute anemia is a consequence of the rupture of high percentages
of pRBCs (Lamikanra et al., 2007). Nevertheless, it is known
that destruction of pRBCs alone cannot account for anemia
severity in malaria patients (Ekvall, 2003; Akinosoglou et al.,
2012). Acute anemia can be observed in both experimental and
human infections presenting low parasitemia and even after
antimalarial treatment and clearance of parasites, anemia can
persist or worsen (Phillips et al., 1986; Camacho et al., 1998;
Carvalho et al., 2003; Helleberg et al., 2005; Evans et al., 2006).
In view of these facts, both ineffective production of RBCs by
the bone marrow and premature elimination of nRBC have
been postulated as important determinants of malaria anemia
pathogenesis (Jakeman et al., 1999; Casals-Pascual et al., 2006;
Evans et al., 2006; Thawani et al., 2014).
The extent of RBC elimination in malaria was reported
in studies estimating that, for every pRBC, up to 32 nRBC
are removed from circulation (Jakeman et al., 1999; Collins
et al., 2003; Evans et al., 2006). In addition, there is evidence
supporting that nRBC removal is mediated by phagocytic activity
rather than intravascular hemolysis (Phillips et al., 1986; Abdalla,
1988; Goka et al., 2001; La Raja, 2002; Satpathy et al., 2004;
Evans et al., 2006), highlighting the mononuclear phagocytic
reticuloendothelial system as an important mechanism of
malarial anemia pathogenesis. Indeed, besides directly participate
in malarial anemia by uptake of both pRBCs and nRBCs,
macrophages may also interfere with the erythropoietic process
by limiting systemic bioavailability of recycled iron, the main
source of which is erythrophagocytosis occurring in spleen and
bone marrow (Beaumont and Delaby, 2009; Spottiswoode et al.,
2014). However, the pathways underlying clearance of RBCs in
malarial anemia remain elusive and therefore, apoptosis as a well-
known mechanism of cell depletion participating in cytopenia of
several pathologies could mediate elimination of nRBCs.
MALARIA AND ERYTHROCYTIC
APOPTOSIS INDUCERS
Studies conducted by Dondorp et al. (1999) with P. falciparum-
infected patients demonstrated that similarly to pRBCs, in which
parasites induces drastic changes on the host cell membrane,
nRBCs also present reduced deformability correlating with
anemia severity. This phenomenon, also recorded in nRBC from
P. falciparum in vitro culture and P. yoelii-infected mice (Paul
et al., 2013; Huang et al., 2014), has been related to adsorption
of malaria parasite antigens on the cell surface (Layez et al.,
2005; Omodeo-Salè et al., 2005) and interestingly, more recently
identified as a hallmark of erythrocytic apoptosis (Mindukshev
et al., 2013), raising the possibility that antigens of malaria
parasites have proapoptotic proprieties on RBCs.
Microbes in general could affect proapoptotic pathways in
host cells. Gram-positive and gram-negative bacteria, as well as
protozoan parasites, have been shown to manipulate apoptotic
processes of both infected and non-infected host nucleated
cells via pathogen antigens that act as apoptosis regulatory
molecules through multifarious pathways, impacting on the
outcome of disease (Ulett and Adderson, 2006; Rodrigues
et al., 2012). A diversity of antigens produced by pathogenic
bacteria such as enterotoxins, hemolysins, lethal toxins,
lipotechoic acid, and lipopolysaccharide, have the ability to
promote apoptosis in several types of host cells including T
and B lymphocytes, dendritic cells, monocytes, macrophages,
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neutrophils, endothelial cells, epithelial cells (Ulett and
Adderson, 2006; Carrero and Unanue, 2012). Similarly, malaria
toxins glycosylphosphatidylinositol and hemozoin purified from
P. falciparum showed proapoptotic activity in cardiomyocytes
and erythroblasts, respectively (Wennicke et al., 2008; Lamikanra
et al., 2009). Moreover, such apoptogenic effect of parasite
factors was recorded by incubating brain vascular endothelial
and neuroglia cells with P. falciparum-pRBC conditioned
medium (Wilson et al., 2008), and induction of apoptosis in lung
endothelial cells can additionally take place by physical contact
due to pRBC adhesion phenomenon (Pino et al., 2003).
There are no studies further exploring the proapoptotic
potential of plasmodial antigens in erythrocytic apoptosis.
However, it was already reported that in P. falciparum in
vitro cultures nRBCs are marked by PS externalization (Koka
et al., 2007; Pattanapanyasat et al., 2010), and in our previous
study with BALB/c mice infected by the lethal P. yoelii 17XL
parasites, increased levels of nRBC apoptosis correlated with
hiperparasitemia (Totino et al., 2013), indirectly suggesting that
as do bacterial toxins (listeriolysin from Listeria monocytogenes
and hemolysin from Vibrio parahaemolyticus), peptidoglycan,
and Schistosoma mansoni egg antigens (Lang et al., 2004b;
Föller et al., 2007; Kasinathan and Greenberg, 2010; Jilani et al.,
2012; Abed et al., 2013), plasmodial antigens can play a role in
induction of erythrocytic apoptosis.
Additionally, several host factors have the potential to
modulate erythrocytic apoptosis during malaria (Lang and Lang,
2015). They may comprise: (1) proapoptotic factors whose
increased levels are associated with malarial severity, such as
soluble Fas ligand (sFasL), anti-erythrocyte antibodies, hematin,
granzyme B, and oxidative stress (Das et al., 1993; Waitumbi
et al., 2000; Hermsen et al., 2003; Issifou et al., 2003; Dalko
et al., 2015) and; (2) antiapoptotic factors, i.e., erythropoietin,
vitamin E, and nitric oxide, that show either reduced levels or
low bioavability inmalaria, and consequently, could contribute to
amplify erythrocytic apoptosis induction (Burgmann et al., 1996;
Kulkarni et al., 2003; Sobolewski et al., 2005).
It is also noteworthy that several routine therapeutic drugs
present proapoptotic properties on erythrocytes, which has been
linked to drug-associated anemia (Lang and Lang, 2015). In
vitro studies performed by Alzoubi et al. (2014a,b) showed
that the antimalarial drugs artesunate and lumefantrine have
proapoptotic effect on erythrocytes, possibly through generation
of oxidative stress, a feature already reported for both drugs
(Xie et al., 2005; Abolaji et al., 2013). Thus, the proapoptotic
effect of artesunate and lumefantrine could explain the reduction
of erythrocytic blood parameters reported in healthy rats and
humans (Xie et al., 2005; Kongpatanakul et al., 2009) as well
as in occurrence of acute anemia in malarial patients following
antimalarial drug treatment (De Nardo et al., 2013; Raffray et al.,
2014; Sowunmi et al., 2015).
REMOVING nRBCs IN MALARIA BY
APOPTOSIS
Although it is known that sensitization of nRBCs by antibodies
and complement system contributes to malarial anemia
pathogenesis ((Daniel-Ribeiro et al., 1986); (Daniel-Ribeiro and
Zanini, 2000; Waitumbi et al., 2000), there is evidence indicating
that the elimination of nRBCs could also occur in an opsonin-
independent manner. For instance, a lack of correlation between
RBC sensitization and anemia degree has been reported in some
studies with malarial patients (Abdalla, 1986; Merry et al., 1986)
and a shortened lifespan of nRBCs was observed during P. yoelii
induced-anemia in a B cell-deficient environment provided by
severe combined immunodeficient mice (Salmon et al., 1997). In
addition, in a recently described novel model of severe malarial
anemia presenting low parasitemia, C3−/− mice still developed
acute anemia following P. berghei infection (Harris et al., 2012).
The participation of a nonopsonic phagocytosis in nRBC
elimination and its relation to apoptosis can be sustained by
data concerning the scavenger receptor CD36 and PS. CD36 is
a well-known phagocytic receptor for apoptotic cells that acts via
recognition of PS on the apoptotic cell surface (Greenberg et al.,
2006). Experiments with both monoclonal anti-CD36 antibodies
and CD36-deficient rodent macrophages have shown that CD36
plays also a role in phagocytic uptake of RBC in malaria
(McGilvray et al., 2000; Patel et al., 2004; Ayi et al., 2005). In these
experiments, the contribution of parasite antigens with affinity
to CD36 (e.g., P. falciparum erythrocyte membrane protein 1—
PfEMP-1) on the pRBC surface cannot be ruled out, since
they were performed with pRBC. Nevertheless, intraerythrocytic
plasmodia development progressively induces PS exteriorization
on pRBC as a result of non-selective cation channel activation in
the host RBC membrane (Eda and Sherman, 2002; Lang et al.,
2004a), indicating that pRBC could be removed via PS.
Importantly, PS has been recognized as a key molecule
mediating erythrophagocytosis, as in vitro treatment with
annexin V or PS-containing liposomes is able to inhibit
phagocytosis of senescent or oxidatively stressed RBC, an effect
also achieved with the use of anti-CD36 antibodies (Bratosin
et al., 1997; Tait and Smith, 1999; Mandal et al., 2002). In a
similar way, phagocytosis of RBC from uremic patients, with
increased levels of PS-exposing RBC with great propensity
for phagocytosis, was also inhibited after preincubation of
macrophages with glycerophosphorylserine, a structural derivate
of PS (Bonomini et al., 2001), indicating that PS can mediate
shortened life span of RBC in pathological conditions in which
anemia is a common feature. In this context, anemia has been
associated with the rates of PS-exposing RBC in peritoneal
dialysis and sepsis patients (Bi et al., 2006; Shi et al., 2013) as well
as with erythrophagocytosis mediated by PS in rats treated with
lead or naphthoquinone—two inducers of erythrocytic apoptosis
(Noh et al., 2010; Jang et al., 2011).
Hence, PS exposure on nRBCs induced to apoptosis during
malaria could also be involved in anemia development, as
suggested initially by our studies on lethal P. yoelii experimental
infection, in which the levels of PS-exposing nRBCs were
increased during the stage of infection marked by an acute
anemia (Totino et al., 2010). Both erythrophagocytosis and
PS-exposing RBCs are increased in P. falciparum infected-
children presenting severe anemia as compared to those with
uncomplicated malaria (Fendel et al., 2010). Apoptosis can also
be induced by incubating RBCs from healthy individuals with
plasma from P. falciparum patients, an effect that is not observed
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with plasma from P. vivax infections, which, comparatively to
P. falciparum, are less prone to lead to severe disease (Totino
et al., 2014). Furthermore, since CD36 is a key molecule in
the RBC clearance process, resistance to severe malarial anemia
reported in children with a non-sense CD36 mutation can be
explained, in part, by a deficiency in phagocytosis of apoptotic
nRBCs mediated by CD36-PS interaction (Pain et al., 2001;
Chilongola et al., 2009).
Recently, additional evidence for the contribution of PS to
malarial anemia was reported in a study of mice infected with the
nonlethal (17XNL) P. yoelii (Fernandez-Arias et al., 2016). In this
model, as observed by our group with the lethal (17XL) strain
P. yoelii (Totino et al., 2010), there was a significant increase
in the levels of PS-exposing nRBCs. In addition, it was shown
that P. yoelii infection induces autoantibodies against PS exposed
on nRBCs and that these antibodies enhance anemia when
transferred to infected mice, an effect related to in vitro nRBC
phagocytosis. Importantly, anti-PS antibodies were also detected
in sera from P. falciparum-infected patients and the highest levels
were associated with late postmalarial anemia in nonimmune
travelers. Therefore, besides participating in the pathogenesis
of malarial anemia by directly promoting RBC elimination via
the innate immune receptor CD36, PS may also contributes
antigenically as a target of acquired immune response, a novel
described autoimmune phenomenon in malaria whose source
needs further investigation.
Another cell event that links erythrocytic apoptosis and
anemia is a change in CD47 expression. CD47 is a ubiquitous
glycoprotein expressed on the cell surface that was identified as
a “marker of self ” by suppressing phagocytosis of normal viable
cells through interaction with signal-regulatory protein alpha
(SIRPα), which operates as a inhibitory receptor on phagocytes
(Sosale et al., 2015). Initially identified in studies demonstrating a
rapid in vivo clearance of CD47-deficient RBCs and an increased
in vitro phagocytosis of normal RBCs by macrophages treated
with SIRPα-blocking antibodies, the CD47/SIRPα system of
cell clearance was suggested to play role in anemia of Rhnull
individuals, given that expression of CD47 on normal RBCs
is coupled to Rh antigen complex (Oldenborg et al., 2000).
Indeed, the involvement of CD47 in anemia was also observed
in mild autoimmune hemolytic anemia typical of experimental
nonobese diabetes, which was worsened and became lethal in
CD47-deficient mice (Oldenborg et al., 2002) and in patients with
myelodysplastic syndrome, the degree of anemia was correlated
to the levels of CD47 expressed on erythroblasts (Jiang et al.,
2013). Furthermore, down-regulation of surface CD47 occurring
specifically on platelets was connected to thrombocytopenia of
Escherichia coli infected-mice (Guo et al., 2009), supporting
data suggesting that CD47 participates in cytopenia of different
etiological sources through cell depletion processes.
Comprehensibly CD47/SIRPα self-recognition system has
been implicated in clearance of apoptotic cells. It was
demonstrated that apoptosis of neutrophils and Jurkat cells is
followed by decreased expression of surface CD47 (Lawrence
et al., 2009; Azuma et al., 2011), while in apoptosis of several
other nucleated cell types CD47, initially clustered in lipid rafts,
is diffused on the cell surface, reducing its avidity for SIRPα
(Lv et al., 2015). In both cases, it is believed that the inhibitory
signaling triggered by CD47 via phosphorylation of the SIRPA
cytoplasmic tail is discontinued and consequently, apoptotic cells
are phagocytized. Therefore, elimination of RBCs contributing
to the pathogenesis of malarial anemia could also be a reflex of
CD47 changes during the apoptosis process.
Reduction of surface CD47 expression has been observed
on RBCs maintained under conditions that induce erythrocytic
apoptosis, such as blood storage and hypoxia, as detected by
externalization of PS (Stewart et al., 2005; Mao et al., 2011),
and there is a consensus that in vivo elimination of senescent
RBCs, which are marked by deflagration of apoptotic processes
(Bosman et al., 2005), is regulated by CD47 (Khandelwal et al.,
2007; Burger et al., 2012). Nevertheless, with the exception of
studies with CD47-deficient mice and Rhnull individuals, those
addressing a relationship between RBC CD47 and anemia are
limited. Two studies on warm autoimmune hemolytic anemia
showed no difference in CD47 expression when comparing RBCs
from patients with those from healthy individuals, suggesting
that CD47 does not play a role in the development of this
pathology, in which autoantibodies are well known to be involved
(Ahrens et al., 2006; Barros et al., 2009). However, it has been
demonstrated that CD47, as a regulator of RBC clearance,
is able to overwhelm phagocytosis mediated by antibody and
complement (Oldenborg et al., 2001; Olsson and Oldenborg,
2008). Therefore, the contribution of CD47 to autoimmune
anemia, possibly by means of its reorganization on cell surface
(not assayed in the above mentioned studies), rather than by its
downexpression, cannot be excluded.
In malaria, the role of CD47 has been recently addressed
(Banerjee et al., 2015; Ayi et al., 2016). Parasites of the nonlethal
strain of P. yoelii 17XNL were mostly detected infecting young
RBCs expressing high levels of CD47, suggesting that malaria
parasites could take advantage of negative signaling of CD47 to
avoid early elimination by phagocytosis (Banerjee et al., 2015).
The authors of this study also demonstrated that absence of this
molecule in deficient mice attenuated the course of parasitemia
and notably, converted the lethal infection of P. yoelii YM into
a nonlethal, self-resolving infection characterized by a very low
parasite load (peak of 0.06%). Similar results in a more recent
study (Ayi et al., 2016) showed that CD47-deficiency attenuated
parasitemia and abolished the development of cerebral malaria
in P. berghei ANKA-infected mice, as well as P. falciparum-pRBC
had decreased levels of CD47, a phenomenon that was associated
with both in vitro and in vivo clearance of P. falciparum—and
P. berghei-pRBCs via SIRPα, respectively.
These data raise the possibility that alteration of CD47
expression on apoptotic pRBCs operates as a regulator of
malaria parasite clearance. Although elimination of pRBCs has
a role in pathogenesis of malarial anemia, contrary to RBC
lysis that allows the propagation of merozoites at the end
of schizogony, RBC apoptosis could play a beneficial role
leading intraerythrocytic-developing parasites to degradation by
phagocytosis and consequently reducing parasite burden that
directly promotes anemia through RBC lysis. This protective
role of erythrocytic apoptosis was previously demonstrated by
treating P. berghei-infected mice with the drug aurothiomalate,
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which triggers apoptosis selectively in pRBCs with no effect on
intraerythrocytic parasite development (Alesutan et al., 2010).
This in vivo stimulation of pRBC apoptosis delayed the course
of parasitemia and mortality of mice, suggesting that the use of
drugs to selectively trigger apoptosis pathways in pRBCs could
be a strategy to treat malaria in a manner not propitious to
generation of parasite resistance, since drugs would target the
host cell and not the parasite.
While CD47 changes on pRBCs could play a protector effect,
the same is not expected for nRBCs. As mentioned above, CD47
deficiency is associated with development of anemia as a result of
increased susceptibility of CD47−/− RBC to phagocytosis under
pathological circumstances. Thus, if on one hand RBC clearance
promoted by the absence of CD47 attenuates malaria parasitemia
(pRBC), on the other hand it leads to anemia (nRBC), as observed
in CD47-deficient mice with P. bergheimalaria (Ayi et al., 2016).
This connection between CD47, nRBC and anemia was also
confirmed in a study with wild type mice infected by P. yoelii
17XNL that found a decline in the number of nRBCs expressing
high levels CD47 when RBC counts were falling. An increase in
newly formed RBCs (reticulocytes) that express high levels of
CD47 was detected later at the recovery stage (Fernandez-Arias
et al., 2016), implicating CD47 in the pathogenesis of malarial
anemia through elimination of nRBCs.
Paradoxically, deflagration of apoptosis in nRBCs could
play a protective role in malaria infection. It is well-known
that apoptotic processes represent an innate mechanism
against intracellular parasitism that altruistically drives
parasites to degradation by phagocytosis along with host
parasitized cells, thereby preventing infection of adjacent cells
and pathogen propagation (Williams, 1994). Alternatively,
apoptosis could act in the control of parasitemia limiting
the availability of non-parasitized targeted cells susceptible
to infection, as shown in P. falciparum in vitro culture
where apoptotic nRBCs were refractory to parasite invasion
(Totino et al., 2011). However, this phenomenon offering as
a host protective mechanism for parasite burden control in
malaria while adversely induces anemia, needs to be better
examined.
APOPTOSIS AND DEFECTIVE
ERYTHROPOIESIS
Besides participating in the pathogenesis of malarial anemia
by mediating precocious elimination of nRBC, apoptosis could
interfere with the production of new RBCs, as previously
reported in severe anemia associated to Leishmania donovani
infection in golden hamsters (Lafuse et al., 2013) as well as in
anemia of chronic disease in patients with rheumatoid arthritis
(Papadaki et al., 2002), in which cytokine-mediated apoptosis of
erythroid cells seems to operate.
Anemia in both malaria experimental models and human
infection is followed by an unexpected frequency of peripheral
reticulocytes considering the loss of RBCs, indicating that
impaired erythropoietic activity is an important mechanism
in the pathogenesis of malarial anemia (Chang et al., 2004;
Leowattana et al., 2008; Fendel et al., 2010; Anyona et al.,
2012; Thawani et al., 2014). Infection by P. chabaudi, P. yoelii,
and P. berghei was shown to inhibit development of erythroid
precursors induced by erythropoietin in mice (Thawani et al.,
2014), an effect also achieved by in vitro incubation of human
erythroid cells with hemozoin or proinflamatory cytokines such
as TNF and IFN-γ, whose levels are augmented during malaria
(Means and Krantz, 1991; Casals-Pascual et al., 2006; Awandare
et al., 2011). In addition, in a study with children presenting
several degrees of malarial anemia, ineffective erythropoiesis
was associated with the amount of circulating hemozoin
and TNF, and deposition of hemozoin in bone marrow was
related to abnormal erythroid development in postmortem
analysis of children with severe anemia (Casals-Pascual et al.,
2006).
In this context, proapoptotic effects of hemozoin, TNF and
interferon-γ on erythroid precursors have been described in vitro
(Dai and Krantz, 1999; Lamikanra et al., 2009; Vittori et al., 2010)
and high levels of apoptotic erythroid cells were observed in bone
marrow aspirates of severe malaria patients presenting erythroid
hypoplasia and low percentage of peripheral reticulocytes
(Anantrakulsil et al., 2005). Nevertheless, the capacity of both
TNF and hemozoin to depress erythropoiesis by inducing
apoptosis has not been consensually demonstrated in vitro
(Skorokhod et al., 2010; Awandare et al., 2011) and apoptosis was
not implicated in impaired maturation of erythroblasts during
anemia of experimental P. chabaudi infection (Chang et al.,
2004).
These apparently contradictory results could be related
to the differences between cell lines, since in vitro studies
with hemozoin and TFN were performed with cells from
different sources, i.e., erythroid cell lines or fresh isolated
CD34+ stem cells from PBMC, which have been shown to
exhibit different susceptibility to apoptosis induced by TNF
or hemozoin (Lamikanra et al., 2009; Skorokhod et al., 2010;
Vittori et al., 2010; Awandare et al., 2011). For instance,
erythroid cells derived from human erythroleukaemia K562 cell
line were susceptible to apoptosis induced by TNF, but not
hemozoin, while those cells derived from normal peripheral
blood CD34+ cells were only susceptible to hemozoin-induced
apoptosis, suggesting that these compounds interfere in the
development of erythroid cells through distinct pathways, with
hemozoin inducing apoptosis and TNF triggering non-apoptotic
mechanisms in healthy (non-leukemia) cells. Indeed, a gene
expression profile study of purified primary erythroid cultures
incubated with either TNF or hemozoin showed recently that
both stimuli were able to inhibit erythroid development, with
activation of largely distinct transcriptional programs: hemozoin
up-regulated genes related to regulation of transcription,
cellular stress response and apoptosis, and the majority of
genes up-regulated by TNF was involved in innate and
adaptive immune responses to infection (Lamikanra et al.,
2015).
These data explain, at least in part, the lack of a relationship
between apoptosis and depressed erythropoiesis in severe anemia
of P. chabaudi infection in A/J mice (Chang et al., 2004),
with TNF probably overwhelming the proapoptotic property of
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hemozoin. Although there are no studies concerning the effect
of TNF on hemozoin-induced apoptosis, it has been shown
that P. chabaudi infection in A/J mice is marked by increased
levels of TNF at the time of decreased reticulocyte response
(Jacobs et al., 1996). Additionally, these data illustrate the
well-known concept of the complex multifactorial pathogenesis
of malarial anemia, in which the molecular mechanisms
regulating eythropoiesis in malaria are still poorly understood;
a scenario that reflects a research gap that remains challenging
due to practical and ethical difficulties in obtaining bone marrow
samples from patients with severe malarial anemia, whose
population majority comprises children of African endemic
regions.
CONCLUDING REMARKS
It has become evident that deflagration of cell death processes
by apoptosis is not restrict to nucleated cells, occurring also
in enucleated RBCs, and consequently, contributing to the
development of anemia through precocious elimination of RBCs.
In malaria infection, erythrocytic apoptosis occurs and seems
to play both detrimental and protective roles by inducing
anemia and controlling parasitemia, respectively (Figure 1).
Although the magnitude and dynamics of erythrocytic apoptosis
in malaria are still to be better established, the above reported
connections between apoptosis and anemia open new options
for development of therapy for severe malarial anemia by
exploring the apoptotic machinery, as considered in other
pathologies related to increased induction of apoptosis such
as Alzheimer’s disease, Parkinson’s disease, and sepsis (Jana
and Paliwal, 2007; Hattori et al., 2010). Advances that allow
therapy improvement for severe malaria anemia are, indeed,
urgently needed. The use of adjunctive therapy for severemalarial
anemia has not been well explored, possibly due to the common
requirement for blood transfusion. However, the prevalence of
blood-borne infections such as HIV in malaria endemic areas
limits the availability and safety of blood transfusion (Osaro
and Charles, 2011). Furthermore, blood transfusion shows a
trend toward presentation of severe adverse events and does
not significantly decrease mortality rates, underscoring the
need for new strategies for treating severe malarial anemia
(Meremikwu and Smith, 2000; Obonyo et al., 2007). Thus,
inhibition of cell signaling pathways leading to erythrocytic
apoptosis could be explored as an alternative strategy to
FIGURE 1 | Model of erythrocytic apoptosis involvement in the pathogenesis of malarial anemia. Both parasitic antigens and host factors modulated by
malaria infection generate a favorable environment for precocious induction of erythrocytic apoptosis (black arrows), which can be enhanced by antimalarial drug
treatment, and in the case of parasitized red blood cells (pRBCs), by intraerythrocytic parasite development. Erythrocytic apoptosis provokes cellular changes, i.e., cell
rigidity increase, exposure of phosphatidylserine and downexpression of CD47, that drive pRBC (white arrows) and non-parasitized RBC (nRBC; gray arrows) to
phagocytosis. Elimination of apoptotic nRBCs along with pRBC lysis and erythropoiesis impairment contribute to the development of malarial anemia. Uptake of
apoptotic pRBCs can help control parasite load. In this manner, the pathogenic or protective role of erythrocytic apoptosis in malaria could be a result of increased
apoptosis induction differentially in nRBC and pRBC, respectively.
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mitigate the impact of severe anemia in mortality caused by
malaria.
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